Related Experiment Video
Updated: Jul 14, 2025

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
COVID-19 incidence and outcomes among patients with kidney replacement therapy
Siribha Changsirikulchai1, Pornpen Sangthawan2, Jirayut Janma1
1Division of Nephrology, Department of Medicine, Faculty of Medicine, Srinakharinwirot University, Nakhonnayok, Thailand.
Insights
Patients on hemodialysis (HD) had higher COVID-19 infection rates. Vaccination significantly reduced fatality in kidney patients, underscoring the need for broader vaccine uptake.
Area of Science:
- Nephrology
- Infectious Diseases
- Public Health
Background:
- Investigated COVID-19 outcomes in kidney disease patients undergoing hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KT).
- Focused on patients reimbursed by the National Health Security Office (NHSO).
Purpose of the Study:
- To determine the incidence and fatality rates of COVID-19 among HD, PD, and KT patients.
- To identify factors associated with COVID-19 outcomes, including vaccination status and comorbidities.
Main Methods:
- Retrospective cohort analysis of an electronic-claimed database (January 2020 - December 2021).
- Evaluated 85,305 patients for COVID-19 infection, vaccination status, comorbidities, fatalities, and treatment costs.
- Assessed associations between patient characteristics, vaccination, and fatality.
Main Results:
- COVID-19 infection incidence was 4.9% in HD, 3.4% in PD, and 3.3% in KT patients.
- Vaccination rates were highest in KT (76.93%), followed by HD (70.65%) and PD (51.34%).
- Fatality rates were lower in KT (8.42%) compared to PD (18.41%) and HD (21.40%). Vaccination significantly reduced fatality (OR 0.3 for two doses).
Conclusions:
- Hemodialysis patients exhibited a higher incidence of COVID-19 infection compared to PD and KT patients.
- COVID-19 vaccination is crucial for reducing fatality in kidney disease patients.
- Encouraging vaccination aligns with national health policy to protect vulnerable populations.
Background:
We aimed to investigate the incidence, fatality, and associated factors in patients with hemodialysis (HD), peritoneal dialysis (PD), and kidney transplantation (KT) hospitalized for coronavirus disease 2019 (COVID-19) infection and reimbursed from the National Health Security Office (NHSO).
Methods:
The retrospective cohort analysis was conducted from an electronic-claimed database, and COVID-19 vaccination status was evaluated in patients with HD, PD, and KT from January 2020 to December 2021. There were 85,305 patients reimbursed for HD, PD, and KT by the NHSO. The rates of COVID-19 infection, COVID-19 vaccination, comorbidities, fatalities, and the cost of treatment were evaluated.
Results:
COVID-19 infection was observed in 1,799 of 36,982 HD cases (4.9%), 1,531 of 45,453 PD cases (3.4%), and 95 of 2,870 KT cases (3.3%). Patients receiving COVID-19 vaccinations were most common in the KT group, followed by those with HD and PD (76.93% vs. 70.65% vs. 51.34%, respectively). KT patients had a lower fatality rate compared to those with PD and HD (8.42% vs. 18.41% vs. 21.40%, respectively). Advanced age, diabetes, cardiovascular diseases, and COVID-19 vaccination status were associated with fatality. The adjusted odds ratios of fatality after receiving one or two doses of vaccines were 0.7 (95% confidence interval [CI], 0.6-0.9) and 0.3 (95% CI, 0.2-0.4), respectively. The cost of treatment was highest in patients with HD, followed by PD and KT.
Conclusion:
The incidence of COVID-19 infection was higher in patients with HD than in those with PD or KT. COVID-19 vaccination following the national health policy should be encouraged for these patients to prevent fatality.
Related Concept Videos
Kidney Transplant III: Nursing Management
Kidney Transplant I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Continuous Renal Replacement Therapy
Acute Kidney Injury I: Introduction
Kidney Transplant II: Surgical Procedure

